Amplifier Therapeutics, A Cambrian Bio Pipeline Company, Doses First Patients In Phase 1B Clinical Trial And Closes New Financing From Future Ventures And Ra Capital Management
Round Type
Funding Round
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Amplifier Therapeutics, a Cambrian Bio pipeline company, today announced the dosing of the first patient in the company's Phase 1B clinical trial investigating ATX-304, a peripherally restricted pan-AMPK activator being developed for the treatment of cardiometabolic diseases.
Quick answer
Amplifier Therapeutics raised an undisclosed amount in a Funding Round round, dated October 17, 2023. Investors: Cambrian, Future Ventures and RA Capital Management. Amplifier Therapeutics is based in New York, United States.
- How much did Amplifier Therapeutics raise?
- Amplifier Therapeutics raised an undisclosed amount in a Funding Round round on October 17, 2023.
- Who invested in Amplifier Therapeutics?
- Cambrian, Future Ventures and RA Capital Management are named as investors in this round.
- What does Amplifier Therapeutics do?
- Amplifier Therapeutics, a Cambrian Bio PipeCo, is focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging including metabolic conditions,..
- Where is Amplifier Therapeutics based and how big is it?
- Amplifier Therapeutics is based in New York, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Amplifier Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- MBrace Therapeutics raised $85M (Series B) on November 14, 2023.
- Forward Therapeutics raised $50M (Series A) on November 8, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
- Acasti raised $7.5M on September 25, 2023.
Who to call at Amplifier Therapeutics, and when
A new round usually means Amplifier Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amplifier Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amplifier Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amplifier Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amplifier Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Amplifier Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.